Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H.

N Engl J Med. 1999 Dec 9;341(24):1789-94.

2.

Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery.

Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LL, Scheffer MG, Trocino G, Vigna C, Baars HF, van Urk H, Roelandt JR; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Eur Heart J. 2001 Aug;22(15):1353-8.

PMID:
11465968
3.

Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).

Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Ann Surg. 2009 Jun;249(6):921-6. doi: 10.1097/SLA.0b013e3181a77d00.

PMID:
19474688
4.

Reducing cardiac risk in noncardiac surgery.

Lee TH.

N Engl J Med. 1999 Dec 9;341(24):1838-40. No abstract available.

PMID:
10588971
5.

Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.

Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, van De Ven LL, van Urk H, Roelandt JR; DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiogrpahy).

JAMA. 2001 Apr 11;285(14):1865-73.

PMID:
11308400
6.

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.

Anesthesiology. 2007 Jul;107(1):33-44.

7.
8.

Bisoprolol prevents mortality and myocardial infarction after vascular surgery.

Dickerson LM, Carek PJ.

J Fam Pract. 2000 Mar;49(3):203-4. No abstract available.

PMID:
10735475
9.

Beta-blockade and surgery.

Prichard BN, Robin JM.

Eur Heart J. 2001 Aug;22(15):1253-5. No abstract available.

PMID:
11465960
10.
11.

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.

Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, Simoons ML, van de Ven LL, Vermeulen M, Bax JJ, Lameris TW, Boersma E.

Am Heart J. 2004 Dec;148(6):1047-52. No abstract available.

PMID:
15632892
12.

Beta-blockade for patients undergoing vascular surgery.

Litwack RS, Gilligan DM, DeGruttola V.

N Engl J Med. 2000 Apr 6;342(14):1052; author reply 1052-3. No abstract available.

PMID:
10755897
13.

Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery.

Poldermans D, Arnese M, Fioretti PM, Boersma E, Thomson IR, Rambaldi R, van Urk H.

Circulation. 1997 Jan 7;95(1):53-8.

14.

Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease.

Dávila-Román VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Pérez JE.

J Am Coll Cardiol. 1993 Mar 15;21(4):957-63.

15.

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.

Mangano DT, Layug EL, Wallace A, Tateo I.

N Engl J Med. 1996 Dec 5;335(23):1713-20. Erratum in: N Engl J Med 1997 Apr 3;336(14):1039.

16.

Perioperative beta-blockers for preventing surgery-related mortality and morbidity.

Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD004476. doi: 10.1002/14651858.CD004476.pub2. Review.

PMID:
25233038
17.

Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.

London MJ, Hur K, Schwartz GG, Henderson WG.

JAMA. 2013 Apr 24;309(16):1704-13. doi: 10.1001/jama.2013.4135. Erratum in: JAMA. 2015 Jul 14;314(2):188.

PMID:
23613075
18.
19.

Prognosis of patients with vascular disease after clinical evaluation and dobutamine stress echocardiography.

Ballal RS, Kapadia S, Secknus MA, Rubin D, Arheart K, Marwick TH.

Am Heart J. 1999 Mar;137(3):469-75.

PMID:
10047628
20.

Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.

Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM, du Bois NA, Roelandt JR, van Urk H.

Circulation. 1993 May;87(5):1506-12.

PMID:
8491005

Supplemental Content

Support Center